Post Resch Tallon Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Post Resch Tallon Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$917K	Sell	21,793 -320	-1%	-$10.2K	0.63%	37
2026 Q1	$604K	Buy	22,113 +1,310	+6%	+$38.4K	0.49%	45
2025 Q4	$603K	Sell	20,803 -795	-4%	-$23.9K	0.51%	43
2025 Q3	$600K	Sell	21,598 -1,245	-5%	-$31.5K	0.53%	41
2025 Q2	$556K	Sell	22,843 -3,480	-13%	-$76.3K	0.54%	42
2025 Q1	$527K	Buy	26,323 +300	+1%	+$7.54K	0.54%	42
2024 Q4	$637K	Buy	+26,023	New	+$640K	0.61%	36

Other funds holding ARKG

MFPI

Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM

CFIM

Client First Investment Management West Bend, Wisconsin $237M AUM 90.28% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

PWM

Purus Wealth Management Newport Beach, California $363M AUM 39.16% 1-Year Est. Return

Lauer Wealth Valparaiso, Indiana $167M AUM 23.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Cambridge Advisors Omaha, Nebraska $582M AUM 19.14% 1-Year Est. Return

Post Resch Tallon Group's ARKG Position: Q2 2026 in Review

Post Resch Tallon Group reduced its ARK Genomic Revolution ETF (ARKG) stake by 1.4% in Q2 2026, selling an estimated $10.2K and leaving 21,793 shares worth $917K. The position accounts for 0.63% of the portfolio, ranked #37.

Post Resch Tallon Group first reported a position in ARKG in Q4 2024 and has held it in 7 quarters since. 36 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Post Resch Tallon Group held 21,793 shares of ARK Genomic Revolution ETF worth $917K as of Q2 2026.
Post Resch Tallon Group sold 320 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $10.2K.
ARK Genomic Revolution ETF made up 0.63% of Post Resch Tallon Group's portfolio in Q2 2026, its #37 holding.
Post Resch Tallon Group first reported a position in ARK Genomic Revolution ETF in Q4 2024 and has held it in 7 quarters since.
36 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Post Resch Tallon Group's 13F filing for Q2 2026, filed 7 Jul 2026.